- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 215/42 - Atomes d'azote liés en position 4
Détention brevets de la classe C07D 215/42
Brevets de cette classe: 278
Historique des publications depuis 10 ans
|
14
|
15
|
18
|
16
|
16
|
13
|
12
|
10
|
8
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10812 |
14 |
| Abivax | 121 |
9 |
| Institut Curie | 605 |
9 |
| Universite de Montpellier | 1024 |
8 |
| Janssen Pharmaceutica N.V. | 3304 |
6 |
| The Regents of the University of California | 20410 |
5 |
| Oryzon Genomics S.A. | 106 |
5 |
| University of Louisville Research Foundation, Inc. | 723 |
5 |
| The Board of Regents of the University of Texas System | 2249 |
5 |
| H. Lundbeck A/S | 1253 |
5 |
| Pharma Cinq, LLC | 64 |
5 |
| Takeda Pharmaceutical Company Limited | 2713 |
4 |
| Atengen, Inc. | 9 |
4 |
| Bristol-myers Squibb Company | 4795 |
3 |
| Allergan, Inc. | 2261 |
3 |
| Children's Medical Center Corporation | 1918 |
3 |
| Merial, Inc. | 216 |
3 |
| Ontario Institute for Cancer Research (oicr) | 84 |
3 |
| The Scripps Research Institute | 1341 |
3 |
| St. Jude Children's Research Hospital | 239 |
3 |
| Autres propriétaires | 173 |